Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 28 studies | 51% ± 26% | |
pericyte | 17 studies | 42% ± 21% | |
oligodendrocyte | 13 studies | 38% ± 16% | |
endothelial cell | 10 studies | 45% ± 17% | |
astrocyte | 9 studies | 45% ± 22% | |
adipocyte | 8 studies | 46% ± 20% | |
myofibroblast cell | 6 studies | 37% ± 18% | |
cardiac muscle cell | 6 studies | 86% ± 14% | |
glutamatergic neuron | 6 studies | 34% ± 18% | |
smooth muscle cell | 6 studies | 66% ± 23% | |
adventitial cell | 5 studies | 53% ± 23% | |
microglial cell | 4 studies | 53% ± 35% | |
GABAergic neuron | 4 studies | 29% ± 16% | |
macrophage | 3 studies | 44% ± 33% | |
Mueller cell | 3 studies | 36% ± 6% | |
connective tissue cell | 3 studies | 30% ± 3% | |
ciliated cell | 3 studies | 25% ± 8% | |
mast cell | 3 studies | 41% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 12901.11 | 447 / 459 | 86% | 11.27 | 956 / 1118 |
lung | 99% | 13453.26 | 574 / 578 | 83% | 7.36 | 960 / 1155 |
esophagus | 87% | 8919.55 | 1250 / 1445 | 75% | 5.67 | 138 / 183 |
bladder | 100% | 8797.95 | 21 / 21 | 57% | 3.67 | 287 / 504 |
stomach | 92% | 7098.23 | 331 / 359 | 62% | 6.04 | 178 / 286 |
prostate | 71% | 3421.01 | 174 / 245 | 80% | 5.26 | 400 / 502 |
uterus | 95% | 9089.29 | 161 / 170 | 49% | 4.79 | 224 / 459 |
intestine | 86% | 6417.58 | 831 / 966 | 57% | 4.48 | 302 / 527 |
pancreas | 45% | 1652.27 | 149 / 328 | 90% | 16.46 | 161 / 178 |
ovary | 100% | 25096.49 | 180 / 180 | 35% | 1.56 | 149 / 430 |
thymus | 94% | 7609.03 | 611 / 653 | 36% | 1.65 | 215 / 605 |
skin | 84% | 8736.97 | 1515 / 1809 | 35% | 3.23 | 166 / 472 |
adrenal gland | 79% | 3694.16 | 204 / 258 | 39% | 2.29 | 89 / 230 |
adipose | 99% | 17239.69 | 1195 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 16386.39 | 853 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 11160.41 | 1299 / 1335 | 0% | 0 | 0 / 0 |
brain | 7% | 181.83 | 172 / 2642 | 87% | 8.03 | 613 / 705 |
muscle | 92% | 6258.53 | 739 / 803 | 0% | 0 | 0 / 0 |
kidney | 25% | 1256.18 | 22 / 89 | 34% | 2.07 | 308 / 901 |
spleen | 48% | 1981.64 | 116 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 2.32 | 21 / 45 |
liver | 4% | 141.92 | 10 / 226 | 36% | 2.36 | 147 / 406 |
lymph node | 0% | 0 | 0 / 0 | 31% | 0.86 | 9 / 29 |
eye | 0% | 0 | 0 / 0 | 5% | 0.18 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0014037 | Biological process | Schwann cell differentiation |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_2001046 | Biological process | positive regulation of integrin-mediated signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0030334 | Biological process | regulation of cell migration |
GO_0007517 | Biological process | muscle organ development |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0110011 | Biological process | regulation of basement membrane organization |
GO_0032224 | Biological process | positive regulation of synaptic transmission, cholinergic |
GO_0007411 | Biological process | axon guidance |
GO_0005576 | Cellular component | extracellular region |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0043197 | Cellular component | dendritic spine |
GO_0042383 | Cellular component | sarcolemma |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0098637 | Cellular component | protein complex involved in cell-matrix adhesion |
GO_0043083 | Cellular component | synaptic cleft |
GO_0005604 | Cellular component | basement membrane |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005198 | Molecular function | structural molecule activity |
Gene name | LAMA2 |
Protein name | Laminin subunit alpha-2 splice variant Laminin subunit alpha 2 Mutant laminin subunit alpha 2 Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) |
Synonyms | LAMM |
Description | FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
Accessions | ENST00000617695.5 A0A8I5KQG5 ENST00000498257.6 ENST00000421865.3 P24043 A0A1P8NQC0 A0A8I5KYA2 A0A087WX80 ENST00000466230.2 A0A1P8NQA0 ENST00000688799.1 ENST00000494137.2 A0A1P8NQC4 ENST00000618192.5 A0A087WYF1 |